Skip to main content
. 2013 Nov 15;6(12):2887–2895.

Table 1.

Correlation of Zonula Occludens-1 (ZO-1) expression in tumor tissues with clinicopathologic characteristics in non-small cell lung cancer (NSCLC) patients

NSCLC n Low or no expression High expression Pearson χ2 P

Total 104 35 69
Gender 0.633 0.426
    male 72 26 (36.11) 46 (63.89)
    female 32 9 (28.13) 23 (71.88)
Age at diagnosis (years) 4.151 0.042*
    ≤60 41 9 (21.95) 32 (78.05)
    >60 63 26 (41.27) 37 (58.73)
Tumor diameter (cm) 0.610 0.435
    ≤3 35 10 (28.57) 25 (71.43)
    >3 69 25 (36.23) 44 (63.77)
Histological type 0.003 0.957
    squamous cell carcinoma 47 16 (34.04) 31 (65.96)
    adenocarcinoma 55 19 (34.55) 36 (65.45)
    others 2 0 2
Differentiation 0.926 0.629
    Well 8 3 (37.50) 5 (62.50)
    Moderate 66 24 (36.36) 42 (63.64)
    Poorly 30 8 (26.67) 22 (73.33)
Lymph node metastasis 0.976 0.614
    No regional lymph node metastasis 53 16 (30.19) 37 (69.81)
    Metastasis in ipsilateral peribronchial 27 9 (33.33) 18 (66.67)
    Metastasis in mediastinal 24 10 (41.67) 14 (58.33)
Stage Grouping with TNM 1.641 0.440
    Stage I 50 14 (28.00) 36 (72.00)
    Stage II 28 10 (35.71) 18 (64.29)
    Stage III 26 11 (33.65) 15 (66.35)
*

P<0.05.